Simcere Pharma kicks off $461m Hong Kong IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Simcere Pharma kicks off $461m Hong Kong IPO

Jonathan Breen
October 13, 2020 09:15 AM
biopharma_stocks_adobe_575x375.jpg

Simcere Pharmaceutical Group has begun its Hong Kong listing, opening books for the up-to HK$3.57bn ($460.6m) deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechUBSEquityChina Merchants Bank CoChinaChina International Capital CorpHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article